Carrio I, Cowie MR, Yamazaki J, Udelson J, Camici PG (2010) Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging 3(1):92–100
Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M (2003) Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 41(4):574–581
Article CAS PubMed Google Scholar
Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL (2008) Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J 29(9):1147–1159
Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, Matsui T, Matsuo S, Travin MI, Jacobson AF (2013) A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 6(7):772–784
Stone GW, Abraham WT, Lindenfeld J, Kar S, Grayburn PA, Lim DS, Mishell JM, Whisenant B, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Asch FM, Mack MJ, Investigators C (2023) Five-Year Follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med 388(22):2037–2048
Fukuda K, Hasegawa S, Kawamura T, Waratani N, Hirata K, Higashimori A, Yokoi Y (2021) Changes in cardiac sympathetic nerve activity on (123) I-metaiodobenzylguanidine scintigraphy after MitraClip therapy. ESC Heart Fail 8(2):1590–1595
Article PubMed PubMed Central Google Scholar
Grayburn PA, Sannino A, Packer M (2019) Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 12(2):353–362
Orban M, Karam N, Lubos E, Kalbacher D, Braun D, Deseive S, Neuss M, Butter C, Praz F, Kassar M, Petrescu A, Pfister R, Iliadis C, Unterhuber M, Lurz P, Thiele H, Baldus S, von Bardeleben RS, Blankenberg S, Massberg S, Windecker S, Hausleiter J, Euro SMRI (2021) Impact of proportionality of secondary mitral regurgitation on outcome after transcatheter mitral valve repair. JACC Cardiovasc Imaging 14(4):715–725
Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schafer U, Schillinger W, Wunderlich N, Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve T (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96
Article CAS PubMed Google Scholar
Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K, Matsuo S, Kinuya S (2011) Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol 18(1):82–89
Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, Kinuya S (2014) Multicenter cross-calibration of I-123 Metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol 21(5):970–978
Article PubMed PubMed Central Google Scholar
Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M (2010) Serial cardiac 123I-metaiodobenzylguanidine scintigraphic studies are more useful for predicting cardiac death than one-time scan in patients with chronic heart failure: sub-analysis of our previous report. Nucl Med Commun 31(9):807–813
Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, Matsui T, Matsuo S, Travin MI, Jacobson AF (2014) A prediction model for 5-year cardiac mortality in patients with chronic heart failure using (1)(2)(3)I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 41(9):1673–1682
Article PubMed PubMed Central Google Scholar
Egi R, Fukushima K, Matsusaka Y, Yamane T, Seto A, Matsunari I, Nakajima Y, Nakano S, Kuji I (2024) Cardiac sympathetic nerve function in patients with severe aortic stenosis prior and after transcatheter aortic valve implantation: evaluation by 5-Year risk model. Ann Nucl Cardiol 10(1):6–15
Article PubMed PubMed Central Google Scholar
Treglia G, Stefanelli A, Bruno I, Giordano A (2013) Clinical usefulness of myocardial innervation imaging using Iodine-123-meta-iodobenzylguanidine scintigraphy in evaluating the effectiveness of Pharmacological treatments in patients with heart failure: an overview. Eur Rev Med Pharmacol Sci 17(1):56–68
Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, Investigators A-H (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart Failure) study. J Am Coll Cardiol 55(20):2212–2221
Fukuda Y, Nishio Y, Miyazaki H, Okada Y, Ueda H, Takahashi S, Nakano Y (2025) Prolonged corrected QT interval is associated with cardiac sympathetic nervous function overactivity in patients with severe aortic stenosis: assessment by 123I-metaiodobenzylguanidine myocardial scintigraphy. Heart Vessels 40(11):1048–1057
Article PubMed PubMed Central Google Scholar
Cohen-Solal A, Rouzet F, Berdeaux A, Le Guludec D, Abergel E, Syrota A, Merlet P (2005) Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. J Nucl Med 46(11):1796–1803
Takahashi J, Fukumoto Y (2025) Improvements of cardiac function and metabolic parameters by sodium-glucose cotransporter 2 inhibitors with no significant effects on sympathetic or parasympathetic activity in chronic heart failure. Heart Vessels. https://doi.org/10.1007/s00380-025-02592-w
Article PubMed PubMed Central Google Scholar
D’Ascenzo F, Moretti C, Marra WG, Montefusco A, Omede P, Taha S, Castagno D, Gaemperli O, Taramasso M, Frea S, Pidello S, Rudolph V, Franzen O, Braun D, Giannini C, Ince H, Perl L, Zoccai G, Marra S, D’Amico M, Maisano F, Rinaldi M, Gaita F (2015) Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol 116(2):325–331
Spieker M, Marpert J, Afzal S, Scheiber D, Bonner F, Horn P, Kelm M, Westenfeld R (2021) Extent and determinants of left ventricular reverse remodeling in patients with secondary mitral regurgitation undergoing MitraClip implantation. Int J Cardiol Heart Vasc 34:100804
PubMed PubMed Central Google Scholar
Markus B, Kreutz J, Chatzis G, Syntila S, Kuchenbuch J, Mueller C, Choukeir M, Schieffer B, Patsalis N (2024) Mitral Valve Transcatheter Edge-to-edge repair (MV-TEER) in patients with secondary mitral regurgitation improves hemodynamics, enhances renal function, and optimizes quality of life in patients with advanced renal insufficiency. Biomedicines 12(11):2642
Koratala A, Kazory A (2017) Natriuretic peptides as biomarkers for congestive states: the cardiorenal divergence. Dis Markers 2017:1454986
Article PubMed PubMed Central Google Scholar
Ammar LA, Massoud GP, Chidiac C, Booz GW, Altara R, Zouein FA (2025) BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: a systematic review and meta-analysis. Heart Fail Rev 30(1):45–54
Article CAS PubMed Google Scholar
Yokoyama H, Shishido K, Mizuno S, Yamanaka F, Saito S (2023) Early effect of transcatheter mitral valve repair on cardiac sympathetic nerve activity. Struct Heart 7(3):100153
Article PubMed PubMed Central Google Scholar
Pontico M, Brunotti G, Conte M, Corica F, Cosma L, De Angelis C, De Feo MS, Lazri J, Matto A, Montebello M, Di Rocco A, Frantellizzi V, Farcomeni A, De Vincentis G (2022) The prognostic value of (123)I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review. J Nucl Cardiol 29(4):1799–1809
Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Carrie D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N, Investigators M-F (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379(24):2297–2306
Moonen A, Cao J, Celermajer DS, Ng MKC (2024) Mitral regurgitation proportionality in functional mitral regurgitation and outcomes after mitral valve transcatheter Edge-to-Edge repair: a systematic review and meta-analysis. Struct Heart 8(3):100284
Comments (0)